BACKGROUND: The delta-5 and delta-6 desaturases, encoded by FADS1 and FADS2 genes, are key enzymes in polyunsaturated fatty acid (PUFA) metabolism that catalyze the conversion of linoleic acid (LA) into arachidonic acid (AA) and that of alpha-linolenic acid (ALA) into eicosapentaenoic acid (EPA). Single-nucleotide polymorphisms (SNPs) in FADS1 and FADS2 have been associated with different concentrations of AA and LA, and those associations have possible functional consequences for desaturase activity. OBJECTIVE: We aimed to evaluate the possible association among FADS genotypes, desaturase activity, inflammation, and coronary artery disease (CAD). DESIGN: Thirteen FADS SNPs and the ratio of AA to LA (AA/LA) on red blood cell (RBC) membranes, a marker of desaturase activity, were evaluated in 876 subjects with (n = 610) or without (n = 266) angiographically documented CAD. RESULTS: Both AA/LA and the ratio of EPA to ALA (EPA/ALA) were higher in patients with CAD than in those without CAD, but, in a multiple logistic regression model, only a higher AA/LA resulted an independent risk factor for CAD (odds ratio: 2.55; 95% CI: 1.61, 4.05 for higher compared with lower ratio tertile; P for trend < 0.001). Furthermore, concentrations of high-sensitivity C-reactive protein increased progressively across tertiles of AA/LA. Graded increases in high-sensitivity C-reactive protein concentrations and CAD risk were related to the carriership of FADS haplotypes, including the alleles associated with a higher ratio. CONCLUSION: In populations following a Western diet, subjects carrying FADS haplotypes that are associated with higher desaturase activity may be prone to a proinflammatory response favoring atherosclerotic vascular damage.
BACKGROUND: The delta-5 and delta-6 desaturases, encoded by FADS1 and FADS2 genes, are key enzymes in polyunsaturated fatty acid (PUFA) metabolism that catalyze the conversion of linoleic acid (LA) into arachidonic acid (AA) and that of alpha-linolenic acid (ALA) into eicosapentaenoic acid (EPA). Single-nucleotide polymorphisms (SNPs) in FADS1 and FADS2 have been associated with different concentrations of AA and LA, and those associations have possible functional consequences for desaturase activity. OBJECTIVE: We aimed to evaluate the possible association among FADS genotypes, desaturase activity, inflammation, and coronary artery disease (CAD). DESIGN: Thirteen FADS SNPs and the ratio of AA to LA (AA/LA) on red blood cell (RBC) membranes, a marker of desaturase activity, were evaluated in 876 subjects with (n = 610) or without (n = 266) angiographically documented CAD. RESULTS: Both AA/LA and the ratio of EPA to ALA (EPA/ALA) were higher in patients with CAD than in those without CAD, but, in a multiple logistic regression model, only a higher AA/LA resulted an independent risk factor for CAD (odds ratio: 2.55; 95% CI: 1.61, 4.05 for higher compared with lower ratio tertile; P for trend < 0.001). Furthermore, concentrations of high-sensitivity C-reactive protein increased progressively across tertiles of AA/LA. Graded increases in high-sensitivity C-reactive protein concentrations and CAD risk were related to the carriership of FADS haplotypes, including the alleles associated with a higher ratio. CONCLUSION: In populations following a Western diet, subjects carrying FADS haplotypes that are associated with higher desaturase activity may be prone to a proinflammatory response favoring atherosclerotic vascular damage.
Authors: Shannon R Porenta; Yi-An Ko; Stephen B Gruber; Bhramar Mukherjee; Ana Baylin; Jianwei Ren; Zora Djuric Journal: Cancer Prev Res (Phila) Date: 2013-09-10
Authors: Dariush Mozaffarian; Edmond K Kabagambe; Catherine O Johnson; Rozenn N Lemaitre; Ani Manichaikul; Qi Sun; Millennia Foy; Lu Wang; Howard Wiener; Marguerite R Irvin; Stephen S Rich; Hongyu Wu; Majken K Jensen; Daniel I Chasman; Audrey Y Chu; Myriam Fornage; Lyn Steffen; Irena B King; Barbara McKnight; Bruce M Psaty; Luc Djoussé; Ida Y-D Chen; Jason H Y Wu; David S Siscovick; Paul M Ridker; Michael Y Tsai; Eric B Rimm; Frank B Hu; Donna K Arnett Journal: Am J Clin Nutr Date: 2014-12-10 Impact factor: 7.045
Authors: Sunita Sharma; Xiaobo Zhou; Derek M Thibault; Blanca E Himes; Andy Liu; Stanley J Szefler; Robert Strunk; Mario Castro; Nadia N Hansel; Gregory B Diette; Becky M Vonakis; N Franklin Adkinson; Lydiana Avila; Manuel Soto-Quiros; Albino Barraza-Villareal; Robert F Lemanske; Julian Solway; Jerry Krishnan; Steven R White; Chris Cheadle; Alan E Berger; Jinshui Fan; Meher Preethi Boorgula; Dan Nicolae; Frank Gilliland; Kathleen Barnes; Stephanie J London; Fernando Martinez; Carole Ober; Juan C Celedón; Vincent J Carey; Scott T Weiss; Benjamin A Raby Journal: J Allergy Clin Immunol Date: 2014-06-13 Impact factor: 10.793
Authors: Andrew A Hicks; Peter P Pramstaller; Asa Johansson; Veronique Vitart; Igor Rudan; Peter Ugocsai; Yurii Aulchenko; Christopher S Franklin; Gerhard Liebisch; Jeanette Erdmann; Inger Jonasson; Irina V Zorkoltseva; Cristian Pattaro; Caroline Hayward; Aaron Isaacs; Christian Hengstenberg; Susan Campbell; Carsten Gnewuch; A Cecilej W Janssens; Anatoly V Kirichenko; Inke R König; Fabio Marroni; Ozren Polasek; Ayse Demirkan; Ivana Kolcic; Christine Schwienbacher; Wilmar Igl; Zrinka Biloglav; Jacqueline C M Witteman; Irene Pichler; Ghazal Zaboli; Tatiana I Axenovich; Annette Peters; Stefan Schreiber; H-Erich Wichmann; Heribert Schunkert; Nick Hastie; Ben A Oostra; Sarah H Wild; Thomas Meitinger; Ulf Gyllensten; Cornelia M van Duijn; James F Wilson; Alan Wright; Gerd Schmitz; Harry Campbell Journal: PLoS Genet Date: 2009-10-02 Impact factor: 5.917